{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:04:45Z","timestamp":1794474285674,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903678"],"award-info":[{"award-number":["81903678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-028"],"award-info":[{"award-number":["2021-I2M-1-028"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tube.2024.102579","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T05:22:22Z","timestamp":1731993742000},"page":"102579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identification of BMVC-8C3O as a novel Pks13 inhibitor with anti-tuberculosis activity"],"prefix":"10.1016","volume":"150","author":[{"given":"Tianjun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhou","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tube.2024.102579_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2014.08.012","article-title":"Gene mutations in Mycobacterium tuberculosis: multidrug-resistant TB as an emerging global public health crisis","volume":"95","author":"Mishra","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2024.102579_bib2","series-title":"Global tuberculosis report 2023","author":"World Health","year":"2023"},{"issue":"10","key":"10.1016\/j.tube.2024.102579_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/ciu619","article-title":"Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis","volume":"59","author":"Bastos","year":"2014","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"23","key":"10.1016\/j.tube.2024.102579_bib4","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"The diarylquinoline TMC207 for multidrug-resistant tuberculosis","volume":"360","author":"Diacon","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tube.2024.102579_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jyp.2013.12.002","article-title":"Bedaquiline - the first ATP synthase inhibitor against multi drug resistant tuberculosis","volume":"5","author":"Lakshmanan","year":"2013","journal-title":"J Young Pharm : JYP"},{"issue":"1","key":"10.1016\/j.tube.2024.102579_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40265-014-0331-4","article-title":"Delamanid: a review of its use in patients with multidrug-resistant tuberculosis","volume":"75","author":"Blair","year":"2015","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.tube.2024.102579_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030466","article-title":"OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice","volume":"3","author":"Matsumoto","year":"2006","journal-title":"PLoS Med"},{"issue":"16","key":"10.1016\/j.tube.2024.102579_bib8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s40265-019-01207-9","article-title":"Pretomanid: first approval","volume":"79","author":"Keam","year":"2019","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.tube.2024.102579_bib9","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1164\/rccm.201909-1819LE","article-title":"Bedaquiline-resistant tuberculosis: dark clouds on the horizon","volume":"201","author":"Andres","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.tube.2024.102579_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02383-2019","article-title":"Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients","volume":"55","author":"Nimmo","year":"2020","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.tube.2024.102579_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/cid\/ciz074","article-title":"Emergence of low-level delamanid and bedaquiline resistance during extremely drug-resistant tuberculosis treatment","volume":"69","author":"Polsfuss","year":"2019","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"2","key":"10.1016\/j.tube.2024.102579_bib12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/S0031182016002377","article-title":"Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target","volume":"145","author":"Abrahams","year":"2018","journal-title":"Parasitology"},{"issue":"1","key":"10.1016\/j.tube.2024.102579_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","article-title":"Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis","volume":"18","author":"Takayama","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2024.102579_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115702","article-title":"Targeting polyketide synthase 13 for the treatment of tuberculosis","volume":"259","author":"Xia","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.tube.2024.102579_bib15","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.chembiol.2014.10.011","article-title":"The polyketide synthase Pks13 catalyzes a novel mechanism of lipid transfer in mycobacteria","volume":"21","author":"Gavalda","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.tube.2024.102579_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105110","article-title":"Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads","volume":"114","author":"Wang","year":"2021","journal-title":"Bioorg Chem"},{"issue":"8","key":"10.1016\/j.tube.2024.102579_bib17","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1093\/nar\/gkw145","article-title":"A novel transition pathway of ligand-induced topological conversion from hybrid forms to parallel forms of human telomeric G-quadruplexes","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.tube.2024.102579_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"issue":"11","key":"10.1016\/j.tube.2024.102579_bib19","first-page":"5185","article-title":"Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation","volume":"55","author":"Lu","year":"2011"},{"issue":"1\u20133","key":"10.1016\/j.tube.2024.102579_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1472-9792(02)00089-6","article-title":"Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis","volume":"83","author":"Brennan","year":"2003","journal-title":"Tuberculosis"},{"issue":"8","key":"10.1016\/j.tube.2024.102579_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nchembio.1277","article-title":"Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis","volume":"9","author":"Wilson","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"9","key":"10.1016\/j.tube.2024.102579_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075245","article-title":"Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis","volume":"8","author":"Ioerger","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.tube.2024.102579_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/acs.jmedchem.7b01319","article-title":"Identification of novel coumestan derivatives as polyketide synthase 13 inhibitors against Mycobacterium tuberculosis","volume":"61","author":"Zhang","year":"2018","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.tube.2024.102579_bib24","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1021\/acs.jmedchem.9b00010","article-title":"Identification of novel coumestan derivatives as polyketide synthase 13 inhibitors against Mycobacterium tuberculosis. Part II","volume":"62","author":"Zhang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2024.102579_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112075","article-title":"Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis","volume":"189","author":"Zhao","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.tube.2024.102579_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/anie.201709365","article-title":"An antibacterial \u03b2-lactone kills Mycobacterium tuberculosis by disrupting mycolic acid biosynthesis","volume":"57","author":"Lehmann","year":"2018","journal-title":"Angew Chem"},{"key":"10.1016\/j.tube.2024.102579_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djad142","article-title":"Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancers","author":"Lu","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.tube.2024.102579_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115788","article-title":"EGFR suppression contributes to growth inhibitory activity of G-quadruplex ligands in non-small cell lung cancers","volume":"216","author":"Lu","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.tube.2024.102579_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/mmy\/myz071","article-title":"The antifungal activities and biological consequences of BMVC-12C-P, a carbazole derivative against Candida species","volume":"58","author":"Shen","year":"2020","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.tube.2024.102579_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cell.2017.06.025","article-title":"Development of a novel lead that targets M. tuberculosis polyketide synthase 13","volume":"170","author":"Aggarwal","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tube.2024.102579_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"Adams","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.tube.2024.102579_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215512120","article-title":"The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance","volume":"120","author":"Lake","year":"2023","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979224001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:55:13Z","timestamp":1778615713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979224001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":32,"alternative-id":["S1472979224001057"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2024.102579","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of BMVC-8C3O as a novel Pks13 inhibitor with anti-tuberculosis activity","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2024.102579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102579"}}